Skip to search formSkip to main content

Secondary Central Nervous System Lymphoma

A non-Hodgkin or Hodgkin lymphoma that has metastasized to the central nervous system following the initial presentation in another nodal or… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Background Secondary central nervous system lymphoma (SCNSL) is a rare and aggressive disease, which is defined as secondary… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2017
2017
The prognosis of central nervous system (CNS) relapse of systemic non-Hodgkin lymphoma is poor with 1-year survival historically… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
2017
2017
 
Is this relevant?
2016
2016
Although the survival rates are extremely low for patients with secondary central nervous system lymphoma (SCNSL) treated with… Expand
  • table I
  • figure 1
  • table II
Is this relevant?
2016
2016
2046Background: PCNSL is an aggressive primary brain tumor. Outcome and treatment options are poor for patients with recurrent… Expand
Is this relevant?
2016
2016
Neurolymphomatosis (NL) is a rare disease that can be caused by T cell, B cell or natural killer cell (NK) lymphomas, but most… Expand
  • figure 1
Is this relevant?
2015
2015
Secondary involvement of the CNS by diffuse large B-cell lymphoma (DLBCL) occurs in less than 1% to more than 10% of patients… Expand
Is this relevant?
2011
2011
BackgroundSecondary central nervous system lymphoma (SCNSL) without extra-central nervous system (CNS) involvement is… Expand
Is this relevant?
Review
2010
Review
2010
Central nervous system (CNS) involvement in non-Hodgkin lymphoma is a serious, potentially preventable complication that can… Expand
Is this relevant?
Review
2005
Review
2005
Patients diagnosed with diffuse large-cell lymphoma, peripheral T-cell non-Hodgkin's lymphoma or mantle cell lymphoma (either… Expand
Is this relevant?